VIDEO ACCESS:
MAYO CLINIC CARE NETWORK:  You are being directed here from the video housed in the Care Network portal.

RELEASE:  February 19, 2016
EXPIRATION:  December 31, 2017 (Credit is not available after this expiration date.)

LEARNING OBJECTIVES:
1. Identify the mechanisms whereby increased renal sympathetic nerve activity on renal nerve effectors could cause hypertension.
2. Analyze the strengths and weaknesses of published clinical trials.
3. Emphasize the design of ongoing trials and technical issues that should clarify whether renal denervation has an established role in clinical practice or not.                               

ACCREDITATION:
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

Mayo Clinic College of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS:

• Click the Take Course button below.
• Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes have between 2-5 questions.
• Complete the evaluation.  

TRANSCRIPT:
This credit will appear on your Transcript for permanent record.  To access your transcript, visit My Account, My Activities, RSS Transcript.

DISCLOSURE SUMMARY
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities.  Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:
Bernard Gersh, MB, ChB, DPhil Consultant - Medtronic, Boston Scientific

No relevant financial relationship(s) with industry:
Director(s) and Planning Committee Members: Heidi M. Connolly, M.D., Charanjit S. Rihal, M.D.; Julie A. Mc Adams, Briana R. Rohde

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

QUESTIONS?
Contact:  cme@mayo.edu